Detalhe da pesquisa
1.
The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity.
Br J Cancer
; 126(8): 1168-1177, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969998
2.
Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?
Biochim Biophys Acta
; 1830(3): 2770-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23200745
3.
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors.
Cancer Discov
; 12(5): 1248-1265, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176764
4.
Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging.
Oncotarget
; 9(79): 34972-34989, 2018 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405887
5.
Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency.
Arthritis Res Ther
; 16(4): R151, 2014 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25029910
6.
Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells.
J Nanopart Res
; 15: 2111, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24348091
7.
Theophylline is able to partially revert cachexia in tumour-bearing rats.
Nutr Metab (Lond)
; 9(1): 76, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22909172
8.
Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
Clin Nutr
; 30(1): 33-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20655130